Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
4.450
+0.250 (5.95%)
At close: Jun 26, 2026, 4:00 PM EDT
4.342
-0.108 (-2.42%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $8.94 million as of June 26, 2026. Its market cap has increased by 82.64% in one year.
Market Cap
8.94M
Enterprise Value
-2.93M
1-Year Change
82.64%
Ranking
Category
Stock Price
$4.45
Market Cap Chart
Since October 29, 2021, Quoin Pharmaceuticals's market cap has decreased from $97.17M to $8.94M, a decrease of -90.80%. That is a compound annual growth rate of -40.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 8.94M | -26.18% |
| Dec 31, 2025 | 12.11M | 127.24% |
| Dec 31, 2024 | 5.33M | 10.02% |
| Dec 29, 2023 | 4.84M | -29.65% |
| Dec 30, 2022 | 6.88M | -54.69% |
| Dec 31, 2021 | 15.19M | -84.36% |
| Oct 29, 2021 | 97.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ernexa Therapeutics | 8.63M |
| Aspire Biopharma Holdings | 8.36M |
| Curis | 8.23M |
| Cadrenal Therapeutics | 8.20M |
| Addex Therapeutics | 8.18M |
| PharmaCyte Biotech | 8.15M |
| Bolt Biotherapeutics | 8.07M |
| Kairos Pharma | 8.02M |